{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:08:34Z","timestamp":1793214514969,"version":"4.5.0"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Purpose<\/jats:title>\n<jats:p>To summarize and meta-analyze uveitis characteristics and multiple sclerosis (MS) phenotype of patients with multiple sclerosis-associated uveitis (MSAU) within a systematic review and meta-analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A comprehensive literature search was performed on January 25, 2023, utilizing PubMed, Embase, and Virtual Health Library (VHL) databases. We included studies involving patients with MSAU, such as case series with over 10 patients, cross-sectional, case-control, and cohort studies. Quality and risk of bias were assessed using CLARITY tools and validated metrics like the Hoy et al. and Hassan Murad et al. tools. The pooled analysis focused on 1) uveitis characteristics, 2) ocular complications, 3) MS phenotype, and 3) administered treatments for uveitis and MS. Gender-based subgroup analysis was conducted across continents; heterogeneity was measured using the I2 statistic. Statistical analysis was performed using R software version 4.3.1. The study was registered in PROSPERO with CRD42023453495 number.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Thirty-six studies were analyzed (24 with a low risk of bias, 8 with some concerns, and 4 with a high risk of bias), including 1,257 patients and 2,034 eyes with MSAU. The pooled analysis showed a mean age of 38.2 \u00b1 12.1 years with a notable female predominance (67%, 95% CI [59%-73%]). MS before uveitis was seen in 59% of the cases (95% CI [48%-69%]), while uveitis was present before MS in 38% (95% CI [30%-48%]). The mean age for the first uveitis episode was 35.7 \u00b1 8.3 years, predominantly affecting both eyes (77%, 95% CI [69%-83%], from 23 studies involving 452 patients). Intermediate uveitis was the most frequent anatomical location (68%, 95% CI [49%-82%], from 22 studies involving 530 patients), often following a recurrent course (63%, 95% CI [38%-83%]). Key complications included vision reduction (42%, 95% CI [19%-70%], from five articles involving 90 eyes), macular compromise (45%, 95% CI [20%-73%], from 4 studies involving 95 eyes), and cataracts (46%, 95% CI [32%-61%], from eight articles involving 230 eyes). Concerning MS phenotype, relapsing-remitting MS (RRMS) was the most common subtype (74%, 95% CI [64%-82%], from eight articles involving 134 patients), followed by secondary progressive MS (24%, 95% CI [18%-33%], from eight articles involving 125 patients). The most frequently occurring central nervous lesions were supratentorial (95%, 95% CI [70%-99%], from two articles involving 17 patients) and spinal cord (39%, 95% CI [16%-68%], from two articles involving 29 patients). The mean Expanded Disability Status Scale (EDSS) score and annual recurrence rates were 2.9 \u00b1 0.6 and 1.07 \u00b1 0.56, respectively. Treatment trends showed the prevalent use of Fingolimod (96%, 95% CI [17%-100%], from two articles involving 196 patients), Mycophenolate (48%, 95% CI [11%-87%], from four articles involving 51 patients), and Interferon-beta (43%, 95% CI [24%-65%], from 11 articles involving 325 patients).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>MSAU primarily affects young adult females, typically presenting as bilateral intermediate uveitis with vision-related complications. The most common MS phenotype is RRMS, often associated with supratentorial and spinal cord lesions on imaging. These findings give ophthalmologists and neurologists a comprehensive clinical picture of MSAU, facilitating prompt diagnosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0307455","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T17:29:52Z","timestamp":1729877392000},"page":"e0307455","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"19","author":[{"given":"Paola","family":"Saboya-Galindo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Mej\u00eda-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2703-0977","authenticated-orcid":true,"given":"Carlos","family":"Cifuentes-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8361-2584","authenticated-orcid":true,"given":"Camilo Andr\u00e9s","family":"Rodr\u00edguez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Boada-Robayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"M\u00e9ndez-Marulanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Sebasti\u00e1n","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8175-4485","authenticated-orcid":true,"given":"Laura","family":"Riveros-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gaviria-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0684-1989","authenticated-orcid":true,"given":"Alejandra","family":"de-la-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"pone.0307455.ref001","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"C Walton","year":"2020","journal-title":"Mult Scler"},{"key":"pone.0307455.ref002","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/09273948.2017.1334469","article-title":"Multiple Sclerosis-Associated Uveitis","volume":"25","author":"ET Cunningham","year":"2017","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref003","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and Treatment of Multiple Sclerosis: A Review","volume":"325","author":"MP McGinley","year":"2021","journal-title":"JAMA"},{"key":"pone.0307455.ref004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"AT Toosy","year":"2014","journal-title":"The Lancet Neurology"},{"key":"pone.0307455.ref005","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1177\/11206721211069457","article-title":"Ocular manifestations of multiple sclerosis in patients from three countries: A Web-based survey","volume":"32","author":"R-Z Zhao","year":"2022","journal-title":"European Journal of Ophthalmology"},{"key":"pone.0307455.ref006","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","article-title":"The 5-year risk of MS after optic neuritis: Experience of the Optic Neuritis Treatment Trial","volume":"49","author":"Optic Neuritis Study Group*","year":"1997","journal-title":"Neurology"},{"key":"pone.0307455.ref007","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/aos.14697","article-title":"Insights into multiple sclerosis\u2010associated uveitis: a scoping review","volume":"99","author":"P Casselman","year":"2021","journal-title":"Acta Ophthalmologica"},{"key":"pone.0307455.ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/565262","article-title":"Gender and Uveitis in Patients with Multiple Sclerosis","volume":"2014","author":"LK Gordon","year":"2014","journal-title":"Journal of Ophthalmology"},{"key":"pone.0307455.ref009","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.survophthal.2016.07.002","article-title":"The association between multiple sclerosis and uveitis","volume":"62","author":"TG Olsen","year":"2017","journal-title":"Survey of Ophthalmology"},{"key":"pone.0307455.ref010","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1177\/1352458511414041","article-title":"Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis","volume":"17","author":"RA Marrie","year":"2011","journal-title":"Mult Scler"},{"key":"pone.0307455.ref011","first-page":"1010","article-title":"Uveitis associated with multiple sclerosis: complications and visual prognosis","volume":"7","author":"D Kaya","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"pone.0307455.ref012","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09273940490895344","article-title":"Multiple sclerosis-associated uveitis","volume":"12","author":"G Zein","year":"2004","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref013","first-page":"1","article-title":"Epidemiological, Clinical, and Therapeutic Profile of Uveitis in Multiple Sclerosis: A Multicenter Study","author":"R Fitoussi","year":"2024","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref014","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"MH Murad","year":"2018","journal-title":"BMJ EBM"},{"key":"pone.0307455.ref015","unstructured":"Google Translate. Available: https:\/\/translate.google.com\/?hl=es&sl=en&tl=es&op=translate"},{"key":"pone.0307455.ref016","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"AJ Thompson","year":"2018","journal-title":"The Lancet Neurology"},{"key":"pone.0307455.ref017","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: Guidelines for research protocols","volume":"13","author":"CM Poser","year":"1983","journal-title":"Annals of Neurology"},{"key":"pone.0307455.ref018","unstructured":"CLARITY Group. Tool to Assess Risk of Bias in Cohort Studies. Available: https:\/\/www.distillersr.com\/resources\/methodological-resources\/tool-to-assess-risk-of-bias-in-cohort-studies-distillersr"},{"key":"pone.0307455.ref019","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"D Hoy","year":"2012","journal-title":"Journal of Clinical Epidemiology"},{"key":"pone.0307455.ref020","unstructured":"CLARITY Group. Tool to Assess Risk of Bias in Case Control Studies. Available: https:\/\/www.distillersr.com\/resources\/methodological-resources\/tool-to-assess-risk-of-bias-in-case-control-studies-distillersr."},{"key":"pone.0307455.ref021","unstructured":"Risk of bias tools\u2014robvis (visualization tool). [cited 7 Dec 2023]. Available: https:\/\/www.riskofbias.info\/welcome\/robvis-visualization-tool"},{"key":"pone.0307455.ref022","unstructured":"Deeks J, Higgins JP, Altman D. Chapter 10: Analysing data and undertaking meta-analyses. Available: https:\/\/training.cochrane.org\/handbook\/current\/chapter-10#section-10-10"},{"key":"pone.0307455.ref023","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/jnnp.52.12.1360","article-title":"Ocular inflammatory changes in established multiple sclerosis","volume":"52","author":"EM Graham","year":"1989","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"pone.0307455.ref024","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0161-6420(91)32324-8","article-title":"Anterior Granulomatous Uveitis in Patients with Multiple Sclerosis","volume":"98","author":"JI Lim","year":"1991","journal-title":"Ophthalmology"},{"key":"pone.0307455.ref025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF00920941","article-title":"Chronic granulomatous anterior uveitis associated with multiple sclerosis","volume":"231","author":"MA Acar","year":"1993","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"pone.0307455.ref026","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.52.1.179","article-title":"Multiple sclerosis associated with uveitis in two large clinic-based series","volume":"52","author":"V Biousse","year":"1999","journal-title":"Neurology"},{"key":"pone.0307455.ref027","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1442-9071.2000.00270.x","article-title":"Symptomatic intraocular inflammation in multiple sclerosis","volume":"28","author":"HM Towler","year":"2000","journal-title":"Clinical Exper Ophthalmology"},{"key":"pone.0307455.ref028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(01)00520-2","article-title":"Patients with Multiple Sclerosis and concomitant uveitis\/periphlebitis retinae are not distinct from those without intraocular inflammation","volume":"187","author":"S Schmidt","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"pone.0307455.ref029","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1076\/ocii.9.2.93.3975","article-title":"Pars planitis: epidemiology, treatment, and association with multiple sclerosis","volume":"9","author":"JF Prieto","year":"2001","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1191\/1352458504ms1087oa","article-title":"A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic","volume":"10","author":"LJ Edwards","year":"2004","journal-title":"Mult Scler"},{"key":"pone.0307455.ref031","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bjo.2004.061119","article-title":"Interferon as a treatment for uveitis associated with multiple sclerosis","volume":"89","author":"MD Becker","year":"2005","journal-title":"British Journal of Ophthalmology"},{"key":"pone.0307455.ref032","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00508-006-0601-6","article-title":"Uveitis and neurologic diseases: an often overlooked relationship","volume":"118","author":"SM Maca","year":"2006","journal-title":"Wien Klin Wochenschr"},{"key":"pone.0307455.ref033","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1352458507083444","article-title":"Uveitis associated with multiple sclerosis","volume":"14","author":"J Le Scanff","year":"2008","journal-title":"Mult Scler"},{"key":"pone.0307455.ref034","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/01658100701551419","article-title":"Symptomatic Uveitis and Multiple Sclerosis","volume":"32","author":"LJ Edwards","year":"2008","journal-title":"Neuro-Ophthalmology"},{"key":"pone.0307455.ref035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":"Uveitis Subtypes in a German Interdisciplinary Uveitis Center\u2014Analysis of 1916 Patients","volume":"36","author":"E Jakob","year":"2009","journal-title":"J Rheumatol"},{"key":"pone.0307455.ref036","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2298\/VSP0912961P","article-title":"Clinical and immunological features of retinal vasculitis in systemic diseases","volume":"66","author":"J Paovic","year":"2009","journal-title":"VSP"},{"key":"pone.0307455.ref037","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458510369146","article-title":"Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study","volume":"16","author":"A Langer-Gould","year":"2010","journal-title":"Mult Scler"},{"key":"pone.0307455.ref038","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/ICO.0b013e3181c2967e","article-title":"Confocal Scan of Keratic Precipitates in Uveitic Eyes of Various Etiologies","volume":"29","author":"MR Kanavi","year":"2010","journal-title":"Cornea"},{"key":"pone.0307455.ref039","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.oftal.2012.04.027","article-title":"Uve\u00edtis asociadas a enfermedad desmielinizante del sistema nervioso central","volume":"87","author":"V Lloren\u00e7","year":"2012","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"},{"key":"pone.0307455.ref040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000341735","article-title":"Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study","volume":"49","author":"AM Karara","year":"2013","journal-title":"Ophthalmic Res"},{"key":"pone.0307455.ref041","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bjophthalmol-2013-304589","article-title":"Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome","volume":"98","author":"C Heinz","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"pone.0307455.ref042","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1352458514539782","article-title":"Uveitis as a prognostic factor in multiple sclerosis","volume":"21","author":"E Shugaiv","year":"2015","journal-title":"Mult Scler"},{"key":"pone.0307455.ref043","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/bjophthalmol-2014-305518","article-title":"Characterisation of uveitis in association with multiple sclerosis","volume":"99","author":"W Messenger","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"pone.0307455.ref044","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.oftal.2016.11.018","article-title":"Eficacia del tratamiento inmunomodulador con interfer\u00f3n-\u03b2 o acetato de glatir\u00e1mero en las uve\u00edtis asociadas a esclerosis m\u00faltiple","volume":"92","author":"D Velazquez-Villoria","year":"2017","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"},{"key":"pone.0307455.ref045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/09273948.2016.1178302","article-title":"Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis","volume":"25","author":"A Hedayatfar","year":"2017","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref046","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/09273948.2015.1125508","article-title":"Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?","volume":"25","author":"L Jouve","year":"2017","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000458157","article-title":"Quantitative Analysis of Uveitis Macular Edema in Multiple Sclerosis Patients Receiving Deep Posterior Sub-Tenon Triamcinolone Acetonide Injection","volume":"58","author":"S Jovanovi\u0107","year":"2017","journal-title":"Ophthalmic Res"},{"key":"pone.0307455.ref048","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ophtha.2018.10.013","article-title":"Uveitis in Patients with Multiple Sclerosis in Clinical Trials of Fingolimod","volume":"126","author":"LL Lim","year":"2019","journal-title":"Ophthalmology"},{"key":"pone.0307455.ref049","doi-asserted-by":"crossref","first-page":"102209","DOI":"10.1016\/j.msard.2020.102209","article-title":"Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study","volume":"43","author":"TR Taylor","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"pone.0307455.ref050","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/09273948.2019.1668429","article-title":"Pattern of Intermediate Uveitis in an Egyptian Cohort","volume":"28","author":"E Abd El Latif","year":"2020","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref051","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/1120672120904667","article-title":"Clinical findings and outcomes of uveitis associated with multiple sclerosis","volume":"31","author":"AF AlBloushi","year":"2021","journal-title":"European Journal of Ophthalmology"},{"key":"pone.0307455.ref052","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1080\/09273948.2022.2103717","article-title":"Occlusive Retinal Vasculitis in Patients with Multiple Sclerosis","volume":"31","author":"AA Saifaldein","year":"2023","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref053","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/09273948.2020.1870145","article-title":"Relevance of Brain MRI in Patients with Uveitis: Retrospective Cohort on 402 Patients","volume":"30","author":"N Chirpaz","year":"2022","journal-title":"Ocular Immunology and Inflammation"},{"key":"pone.0307455.ref054","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1111\/ene.15453","article-title":"Anti\u2010CD20 therapy for multiple sclerosis\u2010associated uveitis: A case series","volume":"29","author":"F Stascheit","year":"2022","journal-title":"Euro J of Neurology"},{"key":"pone.0307455.ref055","doi-asserted-by":"crossref","first-page":"e0264918","DOI":"10.1371\/journal.pone.0264918","article-title":"Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis","volume":"17","author":"E Raskin","year":"2022","journal-title":"PLoS ONE"},{"key":"pone.0307455.ref056","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1749-6632.2011.06116.x","article-title":"Persistent ocular motor manifestations and related visual consequences in multiple sclerosis","volume":"1233","author":"C Tilikete","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"pone.0307455.ref057","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ane.12308","article-title":"Polyautoimmunity in a Greek cohort of multiple sclerosis","volume":"131","author":"G Deretzi","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"pone.0307455.ref058","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/ar3175","article-title":"The autoimmune tautology","volume":"12","author":"J-M Anaya","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"pone.0307455.ref059","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1212\/NXI.0000000000000909","article-title":"Intermediate uveitis associated with MS: Diagnosis, clinical features, pathogenic mechanisms, and recommendations for management","volume":"8","author":"A Abraham","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"pone.0307455.ref060","first-page":"2568","article-title":"The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27","volume":"32","author":"A Linssen","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pone.0307455.ref061","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1167\/iovs.11-8163","article-title":"IL2RA Gene Polymorphism rs2104286 A>G Seen in Multiple Sclerosis Is Associated with Intermediate Uveitis: Possible Parallel Pathways?","volume":"52","author":"E Lindner","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pone.0307455.ref062","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.434","article-title":"Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource","volume":"41","author":"CA Dendrou","year":"2009","journal-title":"Nat Genet"},{"key":"pone.0307455.ref063","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/OPTH.S364200","article-title":"Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses","volume":"16","author":"HH Ghoraba","year":"2022","journal-title":"OPTH"},{"key":"pone.0307455.ref064","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12881-015-0201-2","article-title":"Genetic contribution to multiple sclerosis risk among Ashkenazi Jews","volume":"16","author":"P Khankhanian","year":"2015","journal-title":"BMC Med Genet"},{"key":"pone.0307455.ref065","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/hmg\/7.8.1235","article-title":"DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population","volume":"7","author":"M. Marrosu","year":"1998","journal-title":"Human Molecular Genetics"},{"key":"pone.0307455.ref066","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/1352458514564488","article-title":"The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review","volume":"21","author":"RA Marrie","year":"2015","journal-title":"Mult Scler"},{"key":"pone.0307455.ref067","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/1120672119899379","article-title":"Risk factors for ocular complications in adult patients with uveitis","volume":"30","author":"M Prieto-del-Cura","year":"2020","journal-title":"European Journal of Ophthalmology"},{"key":"pone.0307455.ref068","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2147\/CLEP.S376005","article-title":"The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis","volume":"14","author":"V Perrone","year":"2022","journal-title":"CLEP"},{"key":"pone.0307455.ref069","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","article-title":"Epidemiology of multiple sclerosis","volume":"172","author":"E Leray","year":"2016","journal-title":"Revue Neurologique"},{"key":"pone.0307455.ref070","first-page":"365","article-title":"Cognitive Impairment in Multiple Sclerosis","author":"Elsevier","year":"2016","journal-title":"Translational Neuroimmunology in Multiple Sclerosis"},{"key":"pone.0307455.ref071","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fneur.2017.00234","article-title":"Primary Progressive Multiple Sclerosis: Putting Together the Puzzle","volume":"8","author":"A Abdelhak","year":"2017","journal-title":"Front Neurol"},{"key":"pone.0307455.ref072","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ajhp\/60.7.657","article-title":"Meta-analysis of trials of interventions to improve medication adherence","volume":"60","author":"AM Peterson","year":"2003","journal-title":"American Journal of Health-System Pharmacy"},{"key":"pone.0307455.ref073","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13643-022-01999-0","article-title":"Multivariate meta-analysis of multiple outcomes: characteristics and predictors of borrowing of strength from Cochrane reviews","volume":"11","author":"M Hattle","year":"2022","journal-title":"Syst Rev"},{"key":"pone.0307455.ref074","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.survophthal.2023.09.004","article-title":"Antiviral treatment for acute retinal necrosis: A systematic review and meta-analysis","volume":"69","author":"I Putera","year":"2024","journal-title":"Survey of Ophthalmology"},{"key":"pone.0307455.ref075","doi-asserted-by":"crossref","first-page":"e0296784","DOI":"10.1371\/journal.pone.0296784","article-title":"Quantitative changes in the corneal endothelium and central corneal thickness during anterior chamber inflammation: A systematic review and meta-analysis","volume":"19","author":"G Mej\u00eda-Salgado","year":"2024","journal-title":"PLoS ONE"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T17:30:14Z","timestamp":1729877414000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307455"}},"subtitle":[],"editor":[{"given":"Osamudiamen Cyril","family":"Obasuyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":75,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0307455","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}